ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
Copyright policy )ACAT1/SOAT1 as a Therapeutic Target for Alzheimer's Disease
Alzheimer's disease (AD) is the most common cause of dementia with no cure at present. Cholesterol metabolism is closely associated with AD at several stages. ACAT1 converts free cholesterol to cholesteryl esters, and plays important roles in cellular cholesterol homeostasis. Recent studies show that in a mouse model, blocking ACAT1 provides multiple beneficial effects on AD. Here we review the current evidence that implicates ACAT1 as a therapeutic target for AD. We also discuss the potential usage of various ACAT inhibitors currently available to treat AD.
- Dartmouth College United States
Mice, Alzheimer Disease, Animals, Humans, Acetyl-CoA C-Acetyltransferase, Enzyme Inhibitors, Sterol O-Acyltransferase
Mice, Alzheimer Disease, Animals, Humans, Acetyl-CoA C-Acetyltransferase, Enzyme Inhibitors, Sterol O-Acyltransferase
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).97 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!